1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AVIDITY BIOSCIENCES INC
Avidity Biosciences Inc
XNAS: RNAM

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Avidity Biosciences Inc is on 08 May 2026 for the purpose of Avidity Biosciences Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Avidity Biosciences Inc

The latest disclosure was made by Jean Kim in Avidity Biosciences Inc where a trade of 6,692 Common Stock done was reported to US exchanges on Feb. 27, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jean Kim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 6,692 0 - - Common Stock
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 57,500 0 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 108,000 0 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 50,000 0 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 88,000 0 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 72,000 0 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 96,000 0 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 66,500 0 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 25,000 0 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 150,365 0 - - Common Stock
Jean Kim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 30,000 0 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 65,000 0 - - Stock Option (Right to Buy)
Jean Kim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Jean Kim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,489 0 - - Stock Option (Right to Buy)
Jean Kim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Jean Kim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Tamar Thompson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Tamar Thompson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 6,692 0 - - Common Stock
Tamar Thompson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Tamar Thompson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,489 0 - - Stock Option (Right to Buy)
Tamar Thompson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 115,857 0 - - Common Stock
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,520 0 - - Stock Option (Right to Buy)
Charles Calderaro Chief Technical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 80,000 0 - - Stock Option (Right to Buy)
Charles Calderaro Chief Technical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 98,547 0 - - Common Stock
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 16,000 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 50,000 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,321 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,829 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 9,244 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,352 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 27,584 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 42,480 0 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 50,000 0 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 80,303 0 - - Common Stock
Simona Skerjanec Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 42,308 0 - - Stock Option (Right to Buy)
Simona Skerjanec Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Simona Skerjanec Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 6,692 0 - - Common Stock
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 165,296 0 - - Common Stock
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 106,000 0 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 54,000 0 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 50,000 0 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 78,000 0 - - Stock Option (Right to Buy)
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 6,692 0 - - Common Stock
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Troy E. Wilson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,711 0 - - Common Stock
Troy E. Wilson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 65,091 0 - - Common Stock
Troy E. Wilson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,489 0 - - Stock Option (Right to Buy)
Troy E. Wilson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 15,000 0 - - Stock Option (Right to Buy)
Troy E. Wilson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 15,000 0 - - Stock Option (Right to Buy)
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,489 0 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,489 0 - - Stock Option (Right to Buy)
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 6,692 0 - - Common Stock
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 11,323 0 - - Stock Option (Right to Buy)
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 9,534 0 - - Stock Option (Right to Buy)
Edward M. Kaye Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
John B. Moriarty Chief Legal Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 160,000 0 - - Stock Option (Right to Buy)
John B. Moriarty Chief Legal Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 92,054 0 - - Common Stock
John B. Moriarty Chief Legal Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 50,000 0 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 50,000 0 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 133,977 0 - - Common Stock
Michael F. Maclean Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 92,000 0 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 400,000 0 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 49,333 0 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 68,458 0 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 74,000 0 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 73,342 0 - - Stock Option (Right to Buy)
Eric Mosbrooker Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 79,413 0 - - Common Stock
Eric Mosbrooker Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 50,000 0 - - Stock Option (Right to Buy)
Eric Mosbrooker Chief Commercial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 177,188 0 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 200,000 0 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 300,000 0 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 386,015 0 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 131,250 0 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 425,000 0 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 474,861 0 - - Common Stock
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 300,000 0 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 165,000 0 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 9,534 0 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 11,323 0 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 15,000 0 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Carsten Boess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 6,692 0 - - Common Stock
Carsten Boess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 20,858 0 - - Stock Option (Right to Buy)
Carsten Boess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 15,000 0 - - Stock Option (Right to Buy)
Carsten Boess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Carsten Boess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 22,000 0 - - Stock Option (Right to Buy)
Carsten Boess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,489 0 - - Stock Option (Right to Buy)
Carsten Boess Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 131,372 0 - - Common Stock
Arthur A. Levin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 12,500 0 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 115,500 0 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 144,000 0 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 13,489 0 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 16,562 0 - - Common Stock
Arthur A. Levin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 10,034 0 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 106,000 0 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 60,125 0 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Feb 2026 148,000 0 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 1,758 16,562 - 72.4 127,367 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 2,735 59,290 - 72.5 198,151 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 1,807 62,025 - 72.4 130,917 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 7,993 269,007 - 72.5 579,093 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 6,394 277,000 - 72.4 463,245 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 2,017 34,477 - 72.5 146,132 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 2,878 31,599 - 72.4 208,511 Common Stock
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 3,976 87,651 - 72.4 288,061 Common Stock
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 2,558 85,093 - 72.4 185,327 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 1,476 115,391 - 72.4 106,936 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 72.45 per share. 21 Jan 2026 1,453 113,938 - 72.5 105,270 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 72.23 per share. 07 Jan 2026 1,974 63,832 - 72.2 142,582 Common Stock
John B. Moriarty Chief Legal Officer Sale of securities on an exchange or to another person at price $ 72.23 per share. 07 Jan 2026 2,374 74,557 - 72.2 171,474 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 72.23 per share. 07 Jan 2026 8,576 283,394 - 72.2 619,444 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 72.23 per share. 07 Jan 2026 2,373 36,494 - 72.2 171,402 Common Stock
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 72.23 per share. 07 Jan 2026 2,373 91,627 - 72.2 171,402 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 72.23 per share. 07 Jan 2026 1,965 116,867 - 72.2 141,932 Common Stock
Charles Calderaro Chief Technical Officer Sale of securities on an exchange or to another person at price $ 72.23 per share. 07 Jan 2026 3,727 49,797 - 72.2 269,201 Common Stock
Arthur A. Levin Director Gift of securities by or to the insider at price $ 0.00 per share. 19 Dec 2025 1,330 18,320 - 0 Common Stock
John B. Moriarty Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2025 56,000 103,755 - 0 Common Stock
John B. Moriarty Chief Legal Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 26,824 76,931 - 71.9 1,927,841 Common Stock
Sarah Boyce Director, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 17 Dec 2025 29,159 291,970 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2025 31,000 336,871 - 0 Common Stock
Sarah Boyce Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 15,742 321,129 - 71.9 1,131,378 Common Stock
Eric Mosbrooker Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 36,564 90,436 - 71.9 2,627,855 Common Stock
Eric Mosbrooker Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 11,426 79,010 - 71.9 821,187 Common Stock
Eric Mosbrooker Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2025 72,000 127,000 - 0 Common Stock
W. Michael Flanagan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2025 27,500 107,695 - 0 Common Stock
W. Michael Flanagan Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 13,695 94,000 - 71.9 984,260 Common Stock
Teresa McCarthy Chief Human Resources Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 17,298 118,832 - 71.9 1,243,207 Common Stock
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2025 39,000 136,130 - 0 Common Stock
Kathleen P. Gallagher Chief Program Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 8,030 80,838 - 71.9 577,116 Common Stock
Kathleen P. Gallagher Chief Program Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 33,336 88,868 - 71.9 2,395,858 Common Stock
Kathleen P. Gallagher Chief Program Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2025 72,000 122,204 - 0 Common Stock
Charles Calderaro Chief Technical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. 17 Dec 2025 9,726 53,524 - 71.9 699,008 Common Stock
Charles Calderaro Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2025 23,250 63,250 - 0 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 47.54 per share. 22 Oct 2025 2,209 38,867 - 47.5 105,015 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Oct 2025 2,209 68,458 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. 22 Oct 2025 2,209 41,076 - 10.2 22,443 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 20,000 65,000 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 50.15 per share. 15 Oct 2025 20,000 97,130 - 50.2 1,003,058 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.34 per share. 15 Oct 2025 20,000 117,130 - 22.3 446,800 Common Stock
Eric Mosbrooker Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Oct 2025 6,562 177,188 - - Stock Option (Right to Buy)
Eric Mosbrooker Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 45.38 per share. 03 Oct 2025 6,562 55,000 - 45.4 297,771 Common Stock
Eric Mosbrooker Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. 03 Oct 2025 6,562 61,562 - 9.0 59,386 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. 22 Sep 2025 2,208 41,075 - 10.2 22,433 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2025 2,208 70,667 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 40.58 per share. 22 Sep 2025 2,208 38,867 - 40.6 89,601 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. 15 Sep 2025 1,542 40,409 - 6.6 10,131 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2025 1,542 49,333 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 45.41 per share. 15 Sep 2025 1,542 38,867 - 45.4 70,022 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2025 15,000 85,000 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 41.41 per share. 15 Sep 2025 15,000 97,130 - 41.4 621,143 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.34 per share. 15 Sep 2025 15,000 112,130 - 22.3 335,100 Common Stock
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 38.94 per share. 11 Sep 2025 20,000 80,195 - 38.9 778,702 Common Stock
W. Michael Flanagan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2025 20,000 76,500 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. 11 Sep 2025 20,000 100,195 - 14.2 284,400 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 49.95 per share. 05 Sep 2025 50,000 305,871 - 49.9 2,497,435 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Sep 2025 50,000 1,022,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 05 Sep 2025 50,000 355,871 - 1.2 62,000 Common Stock
Troy E. Wilson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Sep 2025 14,500 0 - - Stock Option (Right to Buy)
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 50.00 per share. 05 Sep 2025 15,000 54,425 - 50 750,000 Common Stock
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 50.00 per share. 05 Sep 2025 14,500 69,425 - 50 725,000 Common Stock
Troy E. Wilson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.48 per share. 05 Sep 2025 14,500 83,925 - 12.5 180,960 Common Stock
Eric Mosbrooker Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2025 6,563 183,750 - - Stock Option (Right to Buy)
Eric Mosbrooker Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 47.07 per share. 03 Sep 2025 6,563 55,000 - 47.1 308,936 Common Stock
Eric Mosbrooker Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. 03 Sep 2025 6,563 61,563 - 9.0 59,395 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 47.42 per share. 02 Sep 2025 188 50,204 - 47.4 8,915 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 49.39 per share. 28 Aug 2025 25,000 305,871 - 49.4 1,234,700 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2025 25,000 1,072,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 28 Aug 2025 25,000 330,871 - 1.2 31,000 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Aug 2025 2,208 72,875 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 46.40 per share. 22 Aug 2025 2,208 38,867 - 46.4 102,462 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. 22 Aug 2025 2,208 41,075 - 10.2 22,433 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.34 per share. 15 Aug 2025 10,000 107,130 - 22.3 223,400 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 46.56 per share. 15 Aug 2025 10,000 97,130 - 46.6 465,632 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2025 10,000 100,000 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Aug 2025 1,542 50,875 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. 13 Aug 2025 1,542 40,409 - 6.6 10,131 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 46.66 per share. 13 Aug 2025 1,542 38,867 - 46.7 71,950 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.34 per share. 06 Aug 2025 107,500 127,150 - 22.3 2,401,550 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 107,500 12,500 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 47.62 per share. 06 Aug 2025 107,500 19,650 - 47.6 5,118,881 Common Stock
Troy E. Wilson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 7,500 14,500 - - Stock Option (Right to Buy)
Troy E. Wilson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 22,000 0 - - Stock Option (Right to Buy)
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 45.00 per share. 06 Aug 2025 17,777 17,776 - 45 799,965 Common Stock
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 45.00 per share. 06 Aug 2025 17,777 17,776 - 45 799,965 Common Stock
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 45.00 per share. 06 Aug 2025 15,000 285,000 - 45 675,000 Common Stock
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 45.00 per share. 06 Aug 2025 15,000 285,000 - 45 675,000 Common Stock
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 45.00 per share. 06 Aug 2025 7,500 69,425 - 45 337,500 Common Stock
Troy E. Wilson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.48 per share. 06 Aug 2025 7,500 76,925 - 12.5 93,600 Common Stock
Troy E. Wilson Director Sale of securities on an exchange or to another person at price $ 45.00 per share. 06 Aug 2025 22,000 69,425 - 45 990,000 Common Stock
Troy E. Wilson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.03 per share. 06 Aug 2025 22,000 91,425 - 12.0 264,660 Common Stock
Eric Mosbrooker Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 124,687 190,313 - - Stock Option (Right to Buy)
Eric Mosbrooker Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 44.06 per share. 06 Aug 2025 6,120 55,000 - 44.1 269,663 Common Stock
Eric Mosbrooker Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 44.06 per share. 06 Aug 2025 124,687 61,120 - 44.1 5,494,033 Common Stock
Eric Mosbrooker Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. 06 Aug 2025 124,687 185,807 - 9.0 1,128,417 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 6,167 74,000 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 17,667 75,083 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 12,334 52,417 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2025 11,283 73,342 - - Stock Option (Right to Buy)
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.74 per share. 06 Aug 2025 33,983 38,867 - 42.7 1,452,342 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.74 per share. 06 Aug 2025 17,667 72,850 - 42.7 755,040 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. 06 Aug 2025 17,667 90,517 - 10.2 179,497 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.74 per share. 06 Aug 2025 6,167 72,850 - 42.7 263,561 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. 06 Aug 2025 6,167 79,017 - 22.5 138,572 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.74 per share. 06 Aug 2025 12,334 72,850 - 42.7 527,122 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. 06 Aug 2025 12,334 85,184 - 6.6 81,034 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.74 per share. 06 Aug 2025 11,283 72,850 - 42.7 482,205 Common Stock
Steven George Hughes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.96 per share. 06 Aug 2025 11,283 84,133 - 16.0 180,077 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 42.73 per share. 06 Aug 2025 30,914 65,806 - 42.7 1,320,844 Common Stock
John B. Moriarty Chief Legal Officer Sale of securities on an exchange or to another person at price $ 36.21 per share. 04 Aug 2025 2,245 47,755 - 36.2 81,291 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 30.24 per share. 17 Jun 2025 911 50,392 - 30.2 27,549 Common Stock
W. Michael Flanagan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. 11 Jun 2025 20,000 100,195 - 14.2 284,400 Common Stock
W. Michael Flanagan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2025 20,000 96,500 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 32.88 per share. 11 Jun 2025 20,000 80,195 - 32.9 657,694 Common Stock
Carsten Boess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 6,692 - 0 Common Stock
Carsten Boess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Arthur A. Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Arthur A. Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 19,650 - 0 Common Stock
Edward M. Kaye Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Edward M. Kaye Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 6,692 - 0 Common Stock
Troy E. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Troy E. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 69,425 - 0 Common Stock
Noreen Roth Henig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 6,692 - 0 Common Stock
Tamar Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Tamar Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 6,692 - 0 Common Stock
Jean Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 6,692 - 0 Common Stock
Jean Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Simona Skerjanec Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 6,692 6,692 - 0 Common Stock
Simona Skerjanec Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 10,034 10,034 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. 02 Jun 2025 5,875 56,429 - 16.7 97,819 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 32.48 per share. 02 Jun 2025 5,875 50,554 - 32.5 190,833 Common Stock
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2025 5,875 22,596 - - Stock Option (Right to Buy)
Kathleen Gallagher P. Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2025 5,875 28,471 - - Stock Option (Right to Buy)
P. Gallagher Kathleen Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. 01 May 2025 5,875 56,429 - 16.7 97,819 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 32.40 per share. 01 May 2025 5,875 50,554 - 32.4 190,324 Common Stock
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.70 per share. 01 Apr 2025 5,546 56,100 - 14.7 81,526 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 27.83 per share. 01 Apr 2025 329 50,554 - 27.8 9,155 Common Stock
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2025 5,546 13,829 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2025 329 34,346 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. 01 Apr 2025 329 50,883 - 16.7 5,478 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 27.83 per share. 01 Apr 2025 5,546 50,554 - 27.8 154,331 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 31.06 per share. 20 Mar 2025 7,935 96,720 - 31.1 246,425 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 31.06 per share. 20 Mar 2025 31,540 305,871 - 31.1 979,563 Common Stock
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 31.06 per share. 20 Mar 2025 11,780 80,195 - 31.1 365,868 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 31.06 per share. 20 Mar 2025 7,778 97,130 - 31.1 241,583 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 31.06 per share. 20 Mar 2025 9,578 72,850 - 31.1 297,491 Common Stock
W. Michael Flanagan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Mar 2025 20,000 116,500 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 30.13 per share. 11 Mar 2025 20,000 91,975 - 30.1 602,614 Common Stock
W. Michael Flanagan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. 11 Mar 2025 20,000 111,975 - 14.2 284,400 Common Stock
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 5,875 19,375 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 29.41 per share. 03 Mar 2025 5,875 50,554 - 29.4 172,807 Common Stock
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.70 per share. 03 Mar 2025 5,875 56,429 - 14.7 86,363 Common Stock
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. 03 Feb 2025 5,875 56,429 - 16.7 97,819 Common Stock
Kathleen P. Gallagher Chief Program Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Feb 2025 5,875 34,675 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 32.16 per share. 03 Feb 2025 5,875 50,554 - 32.2 188,918 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 28.60 per share. 21 Jan 2025 1,872 12,958 - 28.6 53,537 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 1,622 106,320 - 28.6 46,378 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 1,665 104,655 - 28.6 47,608 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 4,738 343,070 - 28.6 135,475 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 5,659 337,411 - 28.6 161,817 Common Stock
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 28.60 per share. 21 Jan 2025 3,860 93,787 - 28.6 110,383 Common Stock
W. Michael Flanagan Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 1,812 91,975 - 28.6 51,809 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 28.60 per share. 21 Jan 2025 1,221 104,908 - 28.6 34,917 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 1,738 106,129 - 28.6 49,695 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 28.60 per share. 21 Jan 2025 670 58,000 - 28.6 19,159 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 30.16 per share. 21 Jan 2025 5,629 50,554 - 30.2 169,776 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 1,817 56,183 - 28.6 51,953 Common Stock
Kathleen P. Gallagher Chief Program Officer Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 1,295 58,670 - 28.6 37,024 Common Stock
Steven George Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 28.59 per share. 21 Jan 2025 2,032 82,428 - 28.6 58,096 Common Stock
George Steven Hughes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 28.60 per share. 21 Jan 2025 1,915 84,460 - 28.6 54,760 Common Stock
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 50,000 50,000 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 25,000 107,942 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 82,500 347,808 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 165,000 165,000 - - Stock Option (Right to Buy)
Eric Mosbrooker Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 50,000 50,000 - - Stock Option (Right to Buy)
Eric Mosbrooker Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 25,000 61,120 - 0 Common Stock
W. Michael Flanagan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 50,000 50,000 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 25,000 97,647 - 0 Common Stock
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 25,000 107,867 - 0 Common Stock
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 50,000 50,000 - - Stock Option (Right to Buy)
Kathleen P. Gallagher Chief Program Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 25,000 59,965 - 0 Common Stock
Kathleen P. Gallagher Chief Program Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 50,000 50,000 - - Stock Option (Right to Buy)
Charles Calderaro Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 80,000 80,000 - - Stock Option (Right to Buy)
Charles Calderaro Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 40,000 40,000 - 0 Common Stock
Hughes George Steven Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 50,000 50,000 - - Stock Option (Right to Buy)
George Hughes Steven Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 25,000 86,375 - 0 Common Stock
Moriarty B. John Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 25,000 50,000 - 0 Common Stock
John Moriarty B. Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 50,000 50,000 - - Stock Option (Right to Buy)
Flanagan Michael W. CSTO Sale of securities on an exchange or to another person at price $ 32.66 per share. 18 Dec 2024 12,742 72,647 - 32.7 416,154 Common Stock
Michael Maclean F. Chief Financial Officer Sale of securities on an exchange or to another person at price $ 32.66 per share. 18 Dec 2024 11,151 82,942 - 32.7 364,192 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 32.66 per share. 18 Dec 2024 31,855 265,308 - 32.7 1,040,384 Common Stock
McCarthy Teresa Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 32.66 per share. 18 Dec 2024 11,151 82,867 - 32.7 364,192 Common Stock
McCarthy Teresa Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 33.26 per share. 16 Dec 2024 25,000 94,018 - 33.3 831,605 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2024 25,000 57,500 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. 16 Dec 2024 25,000 119,018 - 14.2 355,500 Common Stock
Flanagan Michael W. CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2024 24,000 86,000 - - Stock Option (Right to Buy)
W. Flanagan Michael CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. 11 Dec 2024 24,000 109,389 - 22.5 539,280 Common Stock
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 35.77 per share. 11 Dec 2024 24,000 85,389 - 35.8 858,401 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Nov 2024 3,323 0 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 42.12 per share. 19 Nov 2024 3,323 14,830 - 42.1 139,973 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 19 Nov 2024 3,323 18,153 - 1.2 4,121 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. 18 Nov 2024 25,000 119,018 - 14.2 355,500 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Nov 2024 25,000 82,500 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 41.14 per share. 18 Nov 2024 25,000 94,018 - 41.1 1,028,520 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 46.22 per share. 06 Nov 2024 27,262 94,093 - 46.2 1,260,017 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 45.33 per share. 06 Nov 2024 13,875 94,093 - 45.3 629,008 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Nov 2024 65,182 0 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Nov 2024 13,875 60,125 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. 06 Nov 2024 13,875 107,968 - 6.6 91,159 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 45.33 per share. 06 Nov 2024 65,182 94,093 - 45.3 2,954,954 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. 06 Nov 2024 65,182 159,275 - 8.8 574,905 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 46.63 per share. 21 Oct 2024 5,000 14,830 - 46.6 233,168 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Oct 2024 5,000 3,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 21 Oct 2024 5,000 19,830 - 1.2 6,200 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 48.52 per share. 16 Oct 2024 25,000 94,018 - 48.5 1,213,010 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Oct 2024 25,000 107,500 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. 16 Oct 2024 25,000 119,018 - 14.2 355,500 Common Stock
Tamar Thompson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Oct 2024 30,000 0 - - Stock Option (Right to Buy)
Tamar Thompson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.63 per share. 07 Oct 2024 30,000 30,000 - 27.6 828,900 Common Stock
Tamar Thompson Director Sale of securities on an exchange or to another person at price $ 44.98 per share. 07 Oct 2024 30,000 0 - 45.0 1,349,259 Common Stock
W. Michael Flanagan CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.75 per share. 01 Oct 2024 62,500 147,889 - 26.8 1,671,875 Common Stock
W. Michael Flanagan CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2024 62,500 25,000 - - Stock Option (Right to Buy)
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 47.62 per share. 01 Oct 2024 62,500 85,389 - 47.6 2,976,113 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 45.73 per share. 19 Sep 2024 5,000 14,830 - 45.7 228,658 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 19 Sep 2024 5,000 19,830 - 1.2 6,200 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Sep 2024 5,000 8,323 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 25,000 121,355 - 0 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 44.00 per share. 19 Sep 2024 11,510 96,355 - 44 506,440 Common Stock
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 25,000 107,865 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 62,500 267,543 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 62,500 297,163 - 0 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 44.00 per share. 19 Sep 2024 32,880 234,663 - 44.0 1,446,723 Common Stock
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 43.89 per share. 19 Sep 2024 11,847 85,389 - 43.9 519,996 Common Stock
W. Michael Flanagan CSTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 25,000 97,718 - 0 Common Stock
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 44.00 per share. 19 Sep 2024 13,153 72,718 - 44.0 578,737 Common Stock
W. Michael Flanagan CSTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 25,000 85,871 - 0 Common Stock
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 25,000 94,018 - 0 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 44.00 per share. 19 Sep 2024 13,153 69,018 - 44.0 578,737 Common Stock
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2024 25,000 82,171 - 0 Common Stock
W. Michael Flanagan CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.75 per share. 11 Sep 2024 62,500 138,265 - 26.8 1,671,875 Common Stock
W. Michael Flanagan CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2024 34,000 110,000 - - Stock Option (Right to Buy)
W. Michael Flanagan CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2024 62,500 87,500 - - Stock Option (Right to Buy)
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 40.40 per share. 11 Sep 2024 14,894 60,871 - 40.4 601,676 Common Stock
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 40.40 per share. 11 Sep 2024 34,000 75,765 - 40.4 1,373,556 Common Stock
W. Michael Flanagan CSTO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. 11 Sep 2024 34,000 109,765 - 22.5 763,980 Common Stock
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 40.40 per share. 11 Sep 2024 62,500 75,765 - 40.4 2,525,013 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 40.40 per share. 11 Sep 2024 25,000 57,171 - 40.4 1,010,043 Common Stock
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2024 25,000 132,500 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. 11 Sep 2024 25,000 82,171 - 14.2 355,500 Common Stock
Arthur A. Levin Director Gift of securities by or to the insider at price $ 0.00 per share. 06 Sep 2024 22,500 131,372 - 0 Common Stock
Arthur A. Levin Director Gift of securities by or to the insider at price $ 0.00 per share. 06 Sep 2024 22,500 22,500 - 0 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 45.19 per share. 19 Aug 2024 5,000 14,830 - 45.2 225,947 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Aug 2024 5,000 13,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 19 Aug 2024 5,000 19,830 - 1.2 6,200 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 06 Aug 2024 28,000 233,043 - 1.2 34,720 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 43.35 per share. 06 Aug 2024 28,000 205,043 - 43.4 1,213,822 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Aug 2024 28,000 461,015 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 45.01 per share. 19 Jul 2024 5,000 14,830 - 45.0 225,069 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2024 5,000 18,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 19 Jul 2024 5,000 19,830 - 1.2 6,200 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 09 Jul 2024 28,000 233,043 - 1.2 34,720 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jul 2024 28,000 489,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 39.93 per share. 09 Jul 2024 28,000 205,043 - 39.9 1,118,082 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 37.59 per share. 20 Jun 2024 5,000 14,830 - 37.6 187,951 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2024 5,000 23,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 20 Jun 2024 5,000 19,830 - 1.2 6,200 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 39.13 per share. 17 Jun 2024 11,228 57,865 - 39.1 439,345 Common Stock
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 25,000 69,093 - 0 Common Stock
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 25,000 82,865 - 0 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 39.13 per share. 17 Jun 2024 32,074 142,543 - 39.1 1,255,040 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 62,500 205,043 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 62,500 174,617 - 0 Common Stock
W. Michael Flanagan CSTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 25,000 75,765 - 0 Common Stock
W. Michael Flanagan CSTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 25,000 60,871 - 0 Common Stock
W. Michael Flanagan CSTO Sale of securities on an exchange or to another person at price $ 39.13 per share. 17 Jun 2024 10,106 50,765 - 39.1 395,445 Common Stock
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 25,000 57,171 - 0 Common Stock
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 39.13 per share. 17 Jun 2024 9,864 32,171 - 39.1 385,972 Common Stock
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 25,000 42,035 - 0 Common Stock
Carsten Boess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,489 13,489 - - Stock Option (Right to Buy)
Edward M. Kaye Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,489 13,489 - - Stock Option (Right to Buy)
Troy E. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,489 13,489 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,489 13,489 - - Stock Option (Right to Buy)
Tamar Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,489 13,490 - - Stock Option (Right to Buy)
Jean Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,489 13,489 - - Stock Option (Right to Buy)
Arthur A. Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2024 13,489 13,489 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 40.08 per share. 12 Jun 2024 60,000 153,872 - 40.1 2,404,782 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 35.07 per share. 12 Jun 2024 40,000 213,872 - 35.1 1,402,628 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. 12 Jun 2024 104,245 148,338 - 8.8 919,441 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 35.72 per share. 12 Jun 2024 104,245 44,093 - 35.7 3,723,141 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2024 104,245 65,182 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2024 100,000 717,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.08 per share. 12 Jun 2024 35,767 112,117 - 40.1 1,433,484 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 12 Jun 2024 35,767 147,884 - 1.2 44,351 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 40.08 per share. 12 Jun 2024 164,233 112,117 - 40.1 6,581,802 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 12 Jun 2024 164,233 276,350 - 1.2 203,649 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 35.73 per share. 12 Jun 2024 100,000 112,117 - 35.7 3,573,020 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 12 Jun 2024 100,000 212,117 - 1.2 124,000 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2024 35,767 517,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2024 164,233 552,782 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 04 Jun 2024 28,000 140,117 - 1.2 34,720 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jun 2024 28,000 817,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 27.42 per share. 04 Jun 2024 28,000 112,117 - 27.4 767,780 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 May 2024 5,000 28,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 20 May 2024 5,000 19,830 - 1.2 6,200 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 29.90 per share. 20 May 2024 5,000 14,830 - 29.9 149,481 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. 14 May 2024 75,000 119,093 - 8.8 661,500 Common Stock
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 28.28 per share. 14 May 2024 75,000 44,093 - 28.3 2,121,045 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2024 75,000 169,427 - - Stock Option (Right to Buy)
Simona Skerjanec Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2024 42,308 42,308 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 07 May 2024 28,000 140,117 - 1.2 34,720 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2024 28,000 845,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 25.54 per share. 07 May 2024 28,000 112,117 - 25.5 715,050 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Apr 2024 5,000 33,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 19 Apr 2024 5,000 19,830 - 1.2 6,200 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 22.82 per share. 19 Apr 2024 5,000 14,830 - 22.8 114,123 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 27.11 per share. 03 Apr 2024 20,000 253,872 - 27.1 542,214 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 02 Apr 2024 28,000 140,117 - 1.2 34,720 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Apr 2024 28,000 873,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 26.25 per share. 02 Apr 2024 28,000 112,117 - 26.2 734,919 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 23.97 per share. 19 Mar 2024 5,000 14,830 - 24.0 119,848 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Mar 2024 5,000 38,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 19 Mar 2024 5,000 19,830 - 1.2 6,200 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 40,000 244,427 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Sale of securities on an exchange or to another person at price $ 24.52 per share. 13 Mar 2024 40,000 44,093 - 24.5 980,760 Common Stock
Michael F. Maclean Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. 13 Mar 2024 40,000 84,093 - 8.8 352,800 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Mar 2024 25,000 43,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 22.00 per share. 12 Mar 2024 2,641 14,830 - 22 58,102 Common Stock
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 22.04 per share. 12 Mar 2024 25,000 17,471 - 22.0 550,915 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 12 Mar 2024 25,000 42,471 - 1.2 31,000 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 08 Mar 2024 84,000 196,117 - 1.2 104,160 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 21.39 per share. 08 Mar 2024 84,000 112,117 - 21.4 1,796,710 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2024 28,000 901,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2024 84,000 929,015 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 22.63 per share. 08 Mar 2024 28,000 112,117 - 22.6 633,682 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 08 Mar 2024 28,000 140,117 - 1.2 34,720 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 01 Mar 2024 84,000 196,117 - 1.2 104,160 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 20.13 per share. 01 Mar 2024 84,000 112,117 - 20.1 1,691,306 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2024 84,000 1,013,015 - - Stock Option (Right to Buy)
Levin A. Arthur Director Sale of securities on an exchange or to another person at price $ 10.13 per share. 22 Jan 2024 1,859 17,471 - 10.1 18,832 Common Stock
W. Flanagan Michael CSTO Sale of securities on an exchange or to another person at price $ 10.13 per share. 20 Jan 2024 4,129 35,871 - 10.1 41,827 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 10.13 per share. 20 Jan 2024 5,092 44,008 - 10.1 51,582 Common Stock
Maclean F. Michael Chief Financial Officer Sale of securities on an exchange or to another person at price $ 10.13 per share. 20 Jan 2024 1,616 16,884 - 10.1 16,370 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 300,000 300,000 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 10.13 per share. 20 Jan 2024 2,065 17,035 - 10.1 20,918 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 62,500 67,209 - 0 Common Stock
McCarthy Teresa Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 78,000 78,000 - - Stock Option (Right to Buy)
F. Michael Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 106,000 106,000 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 22,500 27,209 - 0 Common Stock
Flanagan Michael W. CSTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 20,000 20,290 - 0 Common Stock
Michael Flanagan W. CSTO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 88,000 88,000 - - Stock Option (Right to Buy)
McCarthy Teresa Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 16,500 17,458 - 0 Common Stock
Troy Wilson E. Director Other type of transaction at price $ 0.00 per share. 12 Dec 2023 250,000 13,711 - 0 Common Stock
Wilson Troy E. Director Other type of transaction at price $ 0.00 per share. 12 Dec 2023 300,000 263,711 - 0 Common Stock
Troy Wilson E. Director Other type of transaction at price $ 0.00 per share. 12 Dec 2023 250,000 300,000 - 0 Common Stock
Troy E. Wilson Director Other type of transaction at price $ 0.00 per share. 12 Dec 2023 300,000 300,000 - 0 Common Stock
Carsten Boess Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Edward M. Kaye Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Troy E. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Noreen Roth Henig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Eric Mosbrooker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Tamar Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Jean Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Arthur A. Levin Director Sale of securities on an exchange or to another person at price $ 22.01 per share. 15 Mar 2023 100 19,330 - 22.0 2,201 Common Stock
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2023 100 68,323 - - Stock Option (Right to Buy)
Arthur A. Levin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 15 Mar 2023 100 19,430 - 1.2 124 Common Stock
Arthur A. Levin Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 14 Feb 2023 10,000 29,330 - 1.2 12,400 Common Stock
Arthur A. Levin Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2023 10,000 68,423 - - Stock Option (Right to Buy)
Arthur A. Levin Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 24.24 per share. 14 Feb 2023 523 19,330 - 24.2 12,677 Common Stock
Arthur A. Levin Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 23.62 per share. 14 Feb 2023 9,477 19,853 - 23.6 223,890 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 24.26 per share. 01 Feb 2023 3,221 53,352 - 24.3 78,141 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 01 Feb 2023 900 54,252 - 1.2 1,116 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 24.27 per share. 01 Feb 2023 900 53,352 - 24.3 21,844 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 01 Feb 2023 45,879 99,231 - 1.2 56,890 Common Stock
Sarah Boyce Director, President and CEO Sale of securities on an exchange or to another person at price $ 24.36 per share. 01 Feb 2023 45,879 53,352 - 24.4 1,117,741 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 01 Feb 2023 3,221 56,573 - 1.2 3,994 Common Stock
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2023 900 1,146,115 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2023 45,879 1,100,236 - - Stock Option (Right to Buy)
Sarah Boyce Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2023 3,221 1,097,015 - - Stock Option (Right to
Arthur A. Levin Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 144,000 144,000 - - Stock Option (Right to Buy)
Arthur A. Levin Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 18,000 19,330 - 0 Common Stock
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 148,000 148,000 - - Stock Option (Right to Buy)
Michael F. Maclean Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 18,500 21,852 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 50,000 53,352 - 0 Common Stock
Sarah Boyce Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 400,000 400,000 - - Stock Option (Right to Buy)
W. Michael Flanagan Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 40,000 40,290 - 0 Common Stock
W. Michael Flanagan Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 144,000 144,000 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 108,000 108,000 - - Stock Option (Right to Buy)
Teresa McCarthy Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 20,000 20,958 - 0 Common Stock
Arthur A. Levin Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 22.00 per share. 12 Jan 2023 10,000 1,330 - 22.0 220,028 Common Stock
Arthur A. Levin Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jan 2023 10,000 78,423 - - Stock Option (Right to Buy)
Arthur A. Levin Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 12 Jan 2023 10,000 11,330 - 1.2 12,400 Common Stock
Arthur A. Levin Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Dec 2022 40,000 88,423 - - Stock Option (Right to Buy)
Arthur A. Levin Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 22.01 per share. 29 Dec 2022 40,000 1,330 - 22.0 880,568 Common Stock
Arthur A. Levin Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.24 per share. 29 Dec 2022 40,000 41,330 - 1.2 49,600 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters